Efficacy and Safety of Recombinant Human Growth Hormone on Height Velocity in Subjects With Idiopathic Short Stature
Status:
Completed
Trial end date:
2014-12-17
Target enrollment:
Participant gender:
Summary
This trial is conducted in Asia. The aim of this trial is to evaluate the efficacy and safety
of recombinant human growth hormone (hGH) in subjects with idiopathic short stature in Korea.